Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;64(2):182-188.
doi: 10.4111/icu.20220366.

Effects of retinoid-loaded hyaluronic acid nanomicelles on vaginal epithelium in a murine menopause model

Affiliations

Effects of retinoid-loaded hyaluronic acid nanomicelles on vaginal epithelium in a murine menopause model

Taehee Kim et al. Investig Clin Urol. 2023 Mar.

Abstract

Purpose: This study aimed to develop hyaluronic acid (HA)-based, retinoic acid (RA)-containing nanomicelles and to investigate the effects of these newly developed nanomicelles on regeneration of the vaginal epithelium and aquaporin 3 (AQP3) expression in a murine menopause model.

Materials and methods: The HA-based, RA-loaded nanomicelles were developed, and the RA-loading rate, encapsulation efficiency, and hydrodynamic diameter were measured. Female BALB/c mice (8 weeks; n=30) were divided into control and experimental groups. Menopause was established in the experimental group by removing both ovaries. The experimental group was further divided into an ovariectomy group, an HA-C18 vehicle group, and an HA-C18-RA group (2.5 µg per mouse); vaginal administration of HA-C18 or HA-C18-RA was performed once daily. After 4 weeks of treatment, murine vaginal tissue was removed, and histological analysis was performed.

Results: Three drug-loaded nanomicelles were synthesized: the RA content in HA-C18-RA-10, HA-C18-RA-20, and HA-C18-RA-30 was 3.13%, 2.52%, and 16.67%, respectively, and the RA encapsulation efficiency was 95.57%, 83.92%, and 93.24%, respectively. In the experimental versus control group, serum estrogen levels were significantly reduced, and the vaginal mucosal epithelial layer was significantly thinner. After 4 weeks of treatment, the thickness of the vaginal mucosal epithelial layer and AQP3 expression was increased in the HA-C18-RA group compared with the HA-C18 vehicle group.

Conclusions: The newly developed HA-based nanomicelles containing RA resulted in vaginal epithelial recovery and increased AQP3 expression. The results may contribute to the development of functional vaginal lubricants or moisturizers for the treatment of vaginal dryness.

Keywords: Aquaporins; Epithelium; Hyaluronic acid; Regeneration; Vagina.

PubMed Disclaimer

Conflict of interest statement

Kwangsung Park has been the Editor-in-Chief of Investigative and Clinical Urology since 2016. The other authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Physicochemical characterization of HA-C18-RA. (A) Mean hydrodynamic diameter. (B) Mean zeta potential and ultraviolet spectra of HA-C18-RA. (C) Ultraviolet-visible spectroscopy of RA in dimethyl sulfoxide and HA-C18-RA in distilled water. HA, hyaluronic acid; RA, retinoic acid; OD, optical density; DMSO, dimethyl sulfoxide.
Fig. 2
Fig. 2. Immunofluorescence results of aquaporin 3 (AQP3) in vaginal tissue from animals in the control (CON), ovariectomized (OVX), ovariectomized plus HA-C18 (HA-C18), and ovariectomized plus HA-C18-RA (HA-C18-RA) groups. AQP3 is mainly expressed throughout the epithelium of vaginal tissue. AQP3 levels decreased in ovariectomized mice compared to controls but were restored by HA-C18-RA treatment. Immunofluorescence images were acquired by confocal microscopy. Data represent at least three independent experiments. DAPI, 4′,6-diamidino-2-phenylindole; HA, hyaluronic acid; RA, retinoic acid.
Fig. 3
Fig. 3. Immunoblotting results of aquaporin 3 (AQP3) in vaginal tissue from animals in the control (CON), ovariectomized (OVX), ovariectomized plus HA-C18 (HA-C18), and ovariectomized plus HA-C18-RA (HA-C18-RA) groups. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HA, hyaluronic acid; RA, retinoic acid. *p<0.05 vs. control. #p<0.05 vs. OVX.

Similar articles

References

    1. Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause. 2010;17:194–203. - PubMed
    1. Alvisi S, Gava G, Orsili I, Giacomelli G, Baldassarre M, Seracchioli R, et al. Vaginal health in menopausal women. Medicina (Kaunas) 2019;55:615. - PMC - PubMed
    1. Leiblum SR, Hayes RD, Wanser RA, Nelson JS. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med. 2009;6:2425–2433. - PubMed
    1. Palacios S. Managing urogenital atrophy. Maturitas. 2009;63:315–318. - PubMed
    1. Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19:151–161. - PMC - PubMed

Publication types